FDA approved the Varipulse pulsed field ablation (PFA) platform for drug refractory paroxysmal atrial fibrillation, Johnson & ...

Johnson & Johnson MedTech has received the US Food and Drug Administration (FDA) approval for its VARIPULSE Platform to treat ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

Johnson & Johnson MedTech announced today that the FDA approved its Varipulse pulsed field ablation (PFA) platform for ...

The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.

Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...

FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...

Johnson & Johnson received Food and Drug Administration approval for its Varipulse pulsed field ablation (PFA) system, ...

The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...

Recent health news highlights include FDA approval for a Johnson & Johnson heart device, Canada's approval of Moderna's RSV ...

Johnson & Johnson MedTech division Biosense Webster has submitted a Premarket Approval Application (PMA) to the US Food and Drug Administration (FDA) for its VARIPULSE Platform, designed to treat ...

In a series of significant industry advancements, the U.S. FDA has given its nod to Johnson & Johnson's Varipulse device ...